Wynik wyszukiwania w bazie Polska Bibliografia Lekarska GBL

Zapytanie: WOLFARTH
Liczba odnalezionych rekordów: 3



Przejście do opcji zmiany formatu | Wyświetlenie wyników w wersji do druku
1/3

Tytuł oryginału: Chronic treatments with haloperidol and clozapine alter the level of NMDA-R1 mRNA in the rat brain: an in situ hybridization study.
Autorzy: Ossowska Krystyna, Pietraszek Małgorzata, Wardas Jadwiga, Dziedzicka-Wasylewska Marta, Nowicka Dorota, Wolfarth Stanisław
Źródło: Pol. J. Pharmacol. 2002: 54 (1) s.1-9, il., bibliogr. 45 poz.
Sygnatura GBL: 313,156

Hasła klasyfikacyjne GBL:
  • farmacja

    Typ dokumentu:
  • praca doświadczalna
  • tytuł obcojęzyczny

    Wskaźnik treści:
  • zwierzęta
  • szczury

    Streszczenie angielskie: The aim of the present study was to examine the influence of 3-month administration of the typical neuroleptic haloperidol (1 mg/kg/day) and the atypical one clozapine (30 mg/kg/day) on the expression of the NMDA-R1 mRNA in different brain structures using in situ hybridization in rats. A long-term treatment with haloperidol decreased the NMDA-R1 mRNA level in intermediate and caudal parts of the caudate-putamen and in more caudally localized regions of parietal and frontal cortices, but increased it in the CA1 region of the hippocampus. No significant changes in the nucleus accumbens, insular cortex, CA3 and dentate gyrus of the hippocampus were found after haloperidol administration. Clozapine did not influence the NMDA-R1 mRNA expression in the hippocampus, as well as in the intermediate and caudal regions of the caudate-putamen, but significantly increased it in the rostral region of the latter structure, in the nucleus accumbens and insular cortex. The present study suggests that both these neuroleptics influence the expression of the mRNA of the NMDA-R1 subunit in brain structures which are thought to be important for development of psychotic symptoms.

    2/3

    Tytuł oryginału: The striatum as a target for anti-rigor effects of an antagonist of mGluR1, but not an agonist of group II metabotropic glutamate receptors.
    Autorzy: Ossowska Krystyna, Konieczny Jolanta, Pilc Andrzej, Wolfarth Stanisław
    Źródło: Brain Res. 2002: 950 (1/2) s.88-94, il., bibliogr. 54 poz.
    Sygnatura GBL: 312,085

    Hasła klasyfikacyjne GBL:
  • farmacja
  • neurologia

    Typ dokumentu:
  • praca doświadczalna
  • praca opublikowana za granicą
  • tytuł obcojęzyczny

    Wskaźnik treści:
  • zwierzęta
  • szczury
  • płeć męska

    Streszczenie angielskie: The aim of the present study was to find out whether the metabotropic receptor 1 (mGluR1) and group II mGluRs, localized in the striatum, are involved in antiparkinonian-like effects in rats. Haloperidol (1 mg/kg ip) induced parkinsonian-like muscle rigidity measured as an increased resistance of a rat's hind foot to passive flexion and extension at the ankle joint. (RS)-1-aminoindian-1,5-dicarboxylic acid (AIDA; 0.5-15 ćg/0.5 ćl), a potent and selective mGluR1 antagonist, or (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate (2R,4R-APDC; 7.5-15 ćg/0.5 ćl), a selective group II agonist, was injected bilaterally into the striatum of haloperidol-treated animals. AIDS in doses of 7.5-15 ć/g/0.5 ćl diminished the haloperidol-induced muscle rigidity. In contrast, 2R,4R-APDC injections were ineffective. The present results may suggest that the blockade of striatal mGluR1, but not the stimulation of group II mGluRs, may ameliorate parkinsonian muscle rigidity.

    3/3

    Tytuł oryginału: Efekty blokady glutaminianergicznych receptorów metabotropowych (mGluR) 1 i 5 w modelach choroby Parkinsona u szczurów.
    Tytuł angielski: Effects of blockade of metabotropic glutamate receptors, subtype 1 and 5 in rat's models of Parkinson's disease.
    Autorzy: Ossowska Krystyna, Wolfarth Stanisław, Konieczny Jolanta, Wardas Jadwiga
    Źródło: Dział. Nauk. PAN 2002 (13) s.114-116, il., bibliogr. 3 poz., sum.
    Sygnatura GBL: 801,551

    Hasła klasyfikacyjne GBL:
  • neurologia

    Wskaźnik treści:
  • zwierzęta
  • szczury

    stosując format: